Measuring Entanglement in a Photonic Embedding Quantum Simulator

Measuring entanglement is a demanding task that usually requires full tomography of a quantum system, involving a number of observables that grows exponentially with the number of parties. Recently, it was suggested that adding a single ancillary qubit would allow for the efficient measurement of concurrence, and indeed any entanglement monotone associated to antilinear operations. Here, we report on the experimental implementation of such a device---an embedding quantum simulator---in photonics, encoding the entangling dynamics of a bipartite system into a tripartite one. We show that bipartite concurrence can be efficiently extracted from the measurement of merely two observables, instead of fifteen, without full tomographic information.Comment: Updated versio

Ultrafine entanglement witnessing

Entanglement witnesses are invaluable for efficient quantum entanglement certification without the need for expensive quantum state tomography. Yet, standard entanglement witnessing requires multiple measurements and its bounds can be elusive as a result of experimental imperfections. Here, we introduce and demonstrate a novel procedure for entanglement detection which simply and seamlessly improves any standard witnessing procedure by using additional available information to tighten the witnessing bounds. Moreover, by relaxing the requirements on the witness operators, our method removes the general need for the difficult task of witness decomposition into local observables. We experimentally demonstrate entanglement detection with our approach using a separable test operator and a simple fixed measurement device for each agent. Finally, we show that the method can be generalized to higher-dimensional and multipartite cases with a complexity that scales linearly with the number of parties

La gestión de la calidad como proceso inherente a la eficacia en las organizaciones

Este artículo pretende demostrar las relaciones que, desde la teoría, se establecen entre de la gestión de la eficacia y su proceso inherente de caracterización de la gestión de la calidad. Se analizó parte del repertorio teórico que versa sobre la gestión de la eficacia organizacional y la caracterización de la gestión de la calidad. La existencia de diversos modelos permitió concluir que la gestión de la eficacia organizacional es un constructo en constante transformación y construcción; a pesar de poder agrupar los diferentes conceptos de calidad en cuatro enfoques fundamentales no existe evidencia teórica de que el constructo haya colapsado, pues es tema de actualidad. Además se concluyó que la gestión de la calidad es un proceso inherente a la gestión de la eficacia organizacional, se asocia al conjunto de actividades coordinadas para dirigir y controlar una organización, se sustenta en ocho principios y es un componente esencial para predecir el comportamiento de la gestión de la eficacia organizacional

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

EDUCACIÓN AMBIENTAL Y SOCIEDAD. SABERES LOCALES PARA EL DESARROLLO Y LA SUSTENTABILIDAD

Este texto contribuye al análisis científico de varias áreas del conocimiento como la filosofía social, la patología, la educación para el cuidado del medio ambiente y la sustentabilidad que inciden en diversas unidades de aprendizaje de la Licenciatura en Educación para la Salud y de la Maestría en Sociología de la SaludLas comunidades indígenas de la sierra norte de Oaxaca México, habitan un territorio extenso de biodiversidad. Sin que sea una área protegida y sustentable, la propia naturaleza de la región ofrece a sus visitantes la riqueza de la vegetación caracterizada por sus especies endémicas que componen un paisaje de suma belleza

Single-active-element demultiplexed multi-photon source

International audienceTemporal-to-spatial demultiplexing routes non-simultaneous events of the same spatial mode to distinct output trajectories. This technique has now been widely adopted because it gives access to higher-number multi-photon states when exploiting solid-state quantum emitters. However, implementations so far have required an always-increasing number of active elements, rapidly facing resource constraints. Here, we propose and demonstrate a demultiplexing approach that utilizes only a single active element for routing to, in principle, an arbitrary number of outputs. We employ our device in combination with a high-efficiency quantum dot based single-photon source, and measure up to eight demultiplexed highly indistinguishable single photons. We discuss the practical limitations of our approach, and describe in which conditions it can be used to demultiplex, e.g., tens of outputs. Our results thus provides a path for the preparation of resource-efficient larger-scale multi-photon sources

CALIDAD AGRONÓMICA DE EFLUENTES DE PLANTAS DE TRATAMIENTO DE AGUAS RESIDUALES

En la ciudad de San Luis Potosí, México, se encuentran en operación seis plantas de tratamiento de aguas residuales, los efluentes son usados en el riego agrícola, lo cual es conveniente tomando en cuenta el clima árido de esta ciudad. Para un mejor aprovechamiento de este recurso se realizó el presente estudio donde se evaluó su calidad agronómica a través de doce indicadores, los cuales no aparecen en la norma oficial mexicana NOM-003-ECOL-1997, la cual especifica la calidad de dichas aguas para su reutilización. Los resultados revelan que los efluentes son de buena calidad en cuanto a RAS (< 10 me L-1) y pH (6.5-8.4). El resto de los indicadores fueron: conductividad eléctrica, salinidad efectiva, salinidad potencial, carbonato de sodio residual, RAS ajustado, reducción de infiltración, cloro, boro, sodio y sólidos disueltos totales, todos ellos resultaron condicionados de manera general. El mejoramiento de estos indicadores, y por lo tanto, la reutilización sustentable de este recurso, es posible a través de diversas opciones tecnológicas que se exponen y que son accesibles a los productores. Una de las medidas relevantes es la adecuación de los instrumentos jurídicos relacionadas a la reutilización agrícola de los efluentes, para tal situación se deberá de crear una mayor evidencia a nivel nacional que refuerce esta propuesta

Active demultiplexing of single photons from a solid-state source

A scheme for active temporal-to-spatial demultiplexing of single photons generated by a solid-state source is introduced. The scheme scales quasi-polynomially with photon number, providing a viable technological path for routing n photons in the one temporal stream from a single emitter to n different spatial modes. Active demultiplexing is demonstrated using a state-of-the-art photon source—a quantum-dot deterministically coupled to a micropillar cavity—and a custom-built demultiplexer—a network of electro-optically reconfigurable waveguides monolithically integrated in a lithium niobate chip. The measured demultiplexer performance can enable a six-photon rate three orders of magnitude higher than the equivalent heralded SPDC source, providing a platform for intermediate quantum computation protocols. (Figure presented.)

Scalable performance in solid-state single-photon sources

The desiderata for an ideal photon source are high brightness, high single-photon purity, and high indistinguishability. Defining brightness at the first collection lens, these properties have been simultaneously demonstrated with solid-state sources; however, absolute source efficiencies remain close to the 1% level and indistinguishability has only been demonstrated for photons emitted consecutively on the few-nanoseconds scale. Here, we employ deterministic quantum dot-micropillar devices to demonstrate solid-state single-photon sources with scalable performances. In one device, an absolute brightness at the output of a single-mode fiber of 14% and purities of 97.1%–99.0% are demonstrated. When nonresontantly excited, it emits a long stream of photons that exhibit indistinguishability up to 70%—above the classical limit of 50%—even after 33 consecutively emitted photons with a 400 ns separation between them. Resonant excitation in other devices results in near-optimal indistinguishability values: 96% at short timescales, remaining at 88% in timescales as large as 463 ns after 39 emitted photons. The performance attained by our devices brings solid-state sources into a regime suitable for scalable implementations